se of Mifepristone along with Misoprostol for medical abortion in second trimester of pregnancy.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Women opting for Medical Termination of pregnancy in second trimester(12-20weeks)
- Registration Number
- CTRI/2013/03/003488
- Lead Sponsor
- Dr Pushpa Junghare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Women wanting to undergo second trimester medical termination of pregnancy (12-20weeks)
Exclusion Criteria
Known hypersensitivity to Mifepristone or Misoprostol
Women with medical renal disease,liver disease
Women with heart disease
Hb less than 8gm%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method